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Extracts of guinea-pig and human skin epidermis were analyzed for prostaglandins PGE1, 
E,, and F"' by radioimmunoassay, and found to contain a total of 62.0 (guinea pig) and 144.7 
(human) ng/gm wet weight. The three prostaglandins occurred in approximately equal 
amounts. 
Guinea-pig epidermal homogenates converted labeled arachidonic acid to PGE, and 
PGF "" the rate of formation being 10 and 2.5 pmoles per mg protein in 0.5 hr, respectively. 
Conversion in the dermis occurred to a much smaller extent. Homogenates of uninvolved and 
involved epidermis from 10 subjects with psoriasis produced PGE, from arachidonic acid at 
rates of 6.48 and 2.97 pmoles per mg protein, respectively, in 0.5 hr. These figures were 
significantly different statistically. The corresponding values for PGF, were 1.10 and 0.51. 
The exposure of guinea-pig epidermal slices to isoproterenol {1-2 x IO-• M) resulted in 
2-fold to 5-fold increases in PGE (PGE, + PGE2 ) levels in the tissue. Levels of PGF '" were 
increased 2-fold at the higher concentration. Guinea-pig epidermal slices incubated with 
PGE, (3-6 X w-. M) and theophylline (2 X w-· M) showed a 6-fold to 9-fold increase in cyclic 
AMP content, measured by radioimmunoassay. The effect of PGE, was less pronounced. 
The lower ability of involved epidermal areas in psoriasis to produce PGE, may account for 
the low levels of cyclic AMP in the lesions. 
Numerous reports indicate that prostaglandins 
(PGs} often increase intracellular levels of cyclic 
adenosine 3',5'-monophosphate (cAMP} by stimu-
lating its formation by adenyl cyclase or inhibiting 
its breakdown by phosphodiesterase [1-10]. In 
psoriatic epidermis, decreased levels of cAMP [11] 
and a possible defective adenyl cyclase have been 
reported 112}. The lowered amounts of cAMP in 
psoriatic epidermis might be the result of an 
inadequate epidermal release of PGs and thus 
these agents may be implicated in the pathophysi-
ology of psoriatic epidermal proliferation. There-
fore, a study of PG release and its action on adenyl 
cyclase in epidermis seemed warranted. 
In the present investigation we have studied the 
occurrence of prostaglandin E, (PGE,}, PGE,, and 
PGF,., in human and guinea-pig epidermis; the 
effect of PGs on epidermal adenyl cyclase; the 
release of PGs by isoproterenol; and the synthesis 
ofPGE, and PGF., from arachidonic acid (20:4*) 
by guinea-pig and psoriatic human epidermis. 
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*Arachidonic acid is designated by 20:4 (number of 
carbon atoms:number of double bonds). 
MATERIALS AND METHODS 
Materials 
The following were obtained from the sources indi-
cated: 1-"C-arachidonic acid (spec act 55.5 mCi/mM) 
from Applied Science Laboratories; tritiated PGE, , 
PGE,, and PGF," (spec act 110-150 Ci/mM) from New 
England Nuclear; precoated silica gel TLC plates (type 
5762) from Brinkmann Instruments lnc.; precoated silica 
gel/10% silver nitrate plates from Analtech Inc. Radio-
immunoassay kits for PGE, PGF"', and cAMP were ob-
tained from Clinical Assays lnc., 237 Binney Street, 
Cambridge, Massachusetts 02142, and Collaborative Re-
search lnc., 1365 Main Street, Waltham, Massachusetts 
02154; DL-isoproterenol, theophylline, and cAMP were 
purchased from Sigma Chemical Co. Other chemicals 
were from J. T. Baker Co. Prostaglandins were gifts 
from the Upjohn Co. 
Tissue Preparation 
Young guinea pigs were sacrificed by exsanguination, 
their skin removed, shaved, and surface debris removed 
with Scotch tape. Epidermal slices were cut with a 
Castroviejo keratotome set to 0.1-mm depth. Slices were 
also obtained from human skin (mastectomy specimens) 
by cutting at 0.2-mm depth, and from patients with 
psoriasis using the keratotome set at 0.4 mm for involved 
skin showing minimal scaling and 0.2 mm for uninvolved 
adjacent skin. These varying depths were selected to give 
almost entirely epidermis with some papillary dermis as 
demonstrated by histologic examination of each skin 
sample. Scales were removed as described from involved 
areas [11] which were locally anesthetized by xylocaine 
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prior to excision. The selected plaques had not been 
treated for the previous 2 weeks. 
Biosynthesis of PGs from 20:4 
The method used was that of Ziboh and Hsia [13], with 
slight ~edification. An epidermal slice (1 em', 40-60 mg 
wet wetght) from human (psoriatic) or guinea-pig skin 
was homogenized and the homogenate centrifuged as 
descnbed by the authors. Protein was determined on the 
supernatant by the Lowry method [14]. An aliquot (1 ml) 
of the supernatant was incubated with 1-"C-20:4 (1 11Ci) 
with cofactors. At the end of incubation, carrier PGE, 
and PGF '" (20 11g of each) were added, and extraction 
and silicic acid column chromatography carried out [13]. 
The 60% and 80% ethyl acetate-benzene eluates were 
pooled and evaporated to about 100 11! which was applied 
as a streak to a silica gel thin-layer chromatography 
(TLC) plate. This was developed with solvent system AI 
used by Green and Samuelsson [15], or, in some experi-
ments, with systems C or E of Nugteren and Hazelhof 
[16). In all cases, reference samples of PGE, and PGF ,. 
(10 11gl were run as spots alongside the streak. These 
reference spots were visualized by spraying with 10% 
ethanolic phosphomolybdic acid and heating for 15 min 
at 120"C. 
Plates were marked off in bands 0.5 em wide as 
described by Ziboh [17], and each band scraped off into 
scintillation vials which were filled with fluid (tolu-
ene:methanol, 9:1 v/v, PPO 4 gm and PO POP 0.2 gm per 
liter) and counted using a Beckman LS-100 scintillation 
spectrometer at 94% efficiency for "C. Quenching due to 
the silica gel was 5%. Recovery ofPGs from the chromato-
graphic procedures was determined by addition of 'H-
PGE, or 'H-PGF,. (50,000 dpm) to reaction mixtures at 
the end of the incubation step, and counting 'H (at 30% 
efficiency) in addition to "C. 
In one experiment, each of the bands opposite the 
PGE, spot was extracted with chloroform: methanol (1:1 
v/v), centrifuged to pellet the silica, and an aliquot of the 
supernatant evaporated and treated with base to gener-
ate absorbance at 278 nm [18]; a second aliquot was 
evaporated and counted. In another experiment, the 
bands opposite PGE, were pooled, extracted, the extract 
evaporated, and the residue base-treated. The alkaline 
solution was acidified to pH 3, extracted with ether [18], 
and the extract evaporated to 100 11! and applied to a 
second TLC plate which was developed with Nugteren's 
system C [16) with an authentic spot of PGB, run 
alongside. Bands opposite this spot were assayed for 
radioactivity and absorbance. 
Determination of PGE, PGE,, and PGF '• by 
Radioimmunoassay 
Epidermal slices (40-60 mg) were incubated at 37°C 
for 15 min with and without isoproterenol (1 or 2 x 10- • 
M) in Bullough buffer, pH 7.4 [19]. Reactions were 
stopped by freezing the flasks in dry ice-acetone. The 
tissue was recovered after partial warming, and immedi-
ately homogenized in ice-cold buffer using a Dual! 
homogenizer. Ethanol (3 vol) was added, the pH adjusted 
to 3.0 by addition of 0.5 N HCl, and the mixtures 
extracted with dichloromethane (3 x 100 ml). The pooled 
extracts were washed with water (2 x 50 ml). Aliquots of 
the extract were evaporated, 0.5 M methanolic KOH (1 
ml) added to the residue, and left for 10 min as described 
in the instructions accompanying the PGE radioim-
munoassay kit. The solutions were extracted with ether 
(3 x 10 ml) after acidifying to pH 3 [18]. The pooled 
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extracts were evaporated and redissolved in a sufficient 
volume of the Tris HCI-NaCI-gelatin buffer (reagent 
"C" of the kit) to provide a concentration of 0.6 to 1.0 ng 
of total PGE (as PGB, i.e., PGB, + PGB,) per ml. Ali-
quots (100 I'll of this solution were analyzed for PGE as 
described in the kit instructions. 
Recovery of PGs was studied by adding 50,000 dpm of 
tritiated PGE,, E,, or F,. to the homogenate, and 
subsequently counting aliquots of the pooled ether ex-
tracts for 'H. 
A standard curve for PGE, and E, was constructed 
using known amounts of each PG (0.01-1.0 ng) which 
were base-treated, extracted as PGB, and subjected to 
the radioimmunoassay procedure as described (Fig. l). 
This curve was used to determine the amounts of PGE in 
experimental solutions. 
Further aliquots of the dichloromethane extracts were 
evaporated and redissolved in a sufficient volume of 
reagent C to provide a concentration of 8.0 to 10.0 ng of 
PGF '"per mi. Aliquots (100 ~til of this solution were used 
in the radioimmunoassay procedure for PGF , •. A stan-
dard curve was established using known amounts of 
PGF,. over the range of 0.14 to 10.0 ng. 
In other experiments, epidermal slices were extracted 
with dichloromethane following homogenization in buffer 
as already described. Each extract was evaporated to 
about 100 ~tl and applied as a streak to silica gel plates 
impregnated with AgNO,_ These were developed and 
PGE, and E, located and extracted from the silica by the 
methods of Willis [20 ]. Each was assayed separately by 
radioimmunoassay. 
Determination of cAMP 
Epidermal slices were incubated with or without PGE-. 
or PGE, (3 or 6 x 10- • M) in Bullough buffer, pH 7.4, 
contmning theophylline (2 mM) at 37"C for 20 min. They 
were immediately frozen in dry ice-acetone and homoge-
nized in ice-cold 6% trichloroacetic acid (1 ml for 10 mg 
wet weight of tissue). The homogenate was centrifuged at 
10,000 x g for 15 min, and the supernatant was extracted 
3 times with 5 ml of ethyl ether saturated with water. 
After extraction, the aqueous phase was heated to 70" to 
80°C to remove ether, evaporated to dryness with a 
stream of nitrogen, and the residue redissolved in 2 ml of 
0.05 M sodium acetate buffer, final pH 6.2. The cAMP 
content of aliquots (0.1 ml) of this solution was deter-
mined by radioimmunoassay, following the instructions 
contained in the kit for cAMP determination. 
For each series of assays, a standard curve was 
constructed usiog samples of cAMP over the range of0.25 
to 25.0 pmoles (Fig. 2). 
., 
< 
~ 
l: 
.. ; 
100~~-
ao-i 
_I 
40-
20-1 
-1 
~'~ 
'"',~' 
~ 
'-"}.... __ 
•oLP_9--,---~~~·· -.~. '• 'lbOPo 
PGB 4 {or PGB2 ) 
--r---·--
1ng 
FIG. 1. Typical standard curve used in radioimmunoas-
say of PGE, and E,. 
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FIG. 2. Typical standard curve used in radioimmunoas-
say of cAMP. 
RESULTS 
Biosynthesis of PGs from 20:4 in Guinea-Pig 
Epidermis 
14C-20:4 was converted to two radioactive prod-
ucts which were partially purified by silicic acid 
column chromatography and then separated by 
silica gel TLC. Radioactivity was detected in those 
bands of the TLC chromatoplates opposite spots of 
authentic PGE, and F '"' Further proof that the 
more mobile of these two bands contained radioac-
tive PGE, was available in the coincidence of 
radioactivity and of absorbance generated at 278 
nm by base treatment of extracts of this zone. In 
other experiments, these bands corresponded to 
authentic PGE, and PGF '" when the plates were 
developed in various solvent systems. Ziboh and 
Hsia [13) have also demonstrated superimposable 
radioactivity and absorbance peaks in reversed 
phase column chromatography. 
The extent of conversion of 14C-20:4 to PGE, and 
PGF'" in 30 min in guinea-pig epidermal homoge-
nate (900 g supernatant fraction) was proportional 
to the amount of soluble protein up to 3 mg per ml 
of protein (Fig. 3). The amount of PGE, and PGF '" 
formed in this time was 4.7 and 1.0 pmoles per mg 
protein, respectively. Recovery of PGE, and PGF20 
was 51.4 ± 4.5% and 44.7 ± 7.1 %, respectively. 
Ziboh and Hsia [13) have reported that 3.0 and 
0.7% of added radioactivity were converted to 
PGE, and PGF'" in preparations containing un-
specified amounts of young rat skin homogenate. 
These results were obtained with skin samples 
which were almost entirely epidermal. When ex-
periments were repeated with purely dermal tissue 
(obtained as a second excision after removal of the 
epidermis with the keratotome at 0.1 mm depth), 
very little synthesis of PGs was observed. Using 
epidermis from 3 guinea pigs, 10.0 ± 2.3 and 1.2 ± 
0.02 pmoles of PGE, and PGF '"' respectively, 
were formed per mg protein in 0.5 hr (means ± 
SD); the corresponding values for dermal tissue 
were 2.0 ± 0.2 and 0.0, respectively. These ob-
servations indicated that PG synthesis occurs 
mainly in the epidermis, though the possibility 
cannot be excluded that it may occur in the papil-
lary layer of the upper dermis. No synthesis of 
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PGs was observed when the supernatant of the 
homogenate was boiled before incubation. 
Biosynthesis of PGs from 20:4 in Epidermis of 
Psoriatic Lesions 
The synthesis of PGE, and PGF,., from "C-20:4 
was studied with homogenates of epidermis from 
involved and uninvolved skin areas of 10 psoriasis 
patients. In 0.5 hr, the conversion to PGE, and 
PGF,~ was 6.48 ± 1.68 and 1.10 ± 0.36 pmoles per 
mg protein, respectively, in uninvolved skin, and 
2.97 ± 1.59 and 0.51 ± 0.22 pmoles in involved 
skin. The PGE, value for involved skin was signifi· 
cantly lower than that of uninvolved (0.01 < p < 
0.02), and this was observed with varying protein 
concentrations (Fig. 4). The values for PGF,a were 
not significantly different. 
Determination of PGs by Radioimmunoassay 
The recovery of PGE 1 and PGE, from the point 
of tissue homogenization through conversion to 
PGB, and 8 2 and reextraction was 96.3 ± 2.1% and 
95.3 ± 1.9%, respectively, up to the point immedi-
ately prior to radioimmunoassay. The correspond-
ing figure for PGF,a was 91.2 ± 4.1%. Values for 
experiments in which the PGs were subjected to 
TLC on AgN03 -impregnated plates were 49.3 ± 
5.7%, and 45.1 ± 5.1% for PGE, and PGE,, 
respectively. 
The standard curves showing the percent inhibi-
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tion of 'H-PGB or 'H-PGF2a binding to their 
respective antisera by PGB or PGF '" were almost 
exactly reproducible on the five occasions on which 
they were plotted. Duplicate determinations on 2 
aliquots of the experimental solutions did not 
differ from each other by more than 5% of the mean 
value. On three occasions, the addition of 40 pg of 
PGE2 to each of 3 experimental samples increased 
the inhibition reading by 97 to 102% of the theoreti-
cal increase irrespective of whether or not the 
samples had been subjected to AgNO,-TLC. The 
curves for PGB, and PGB, (PGE, and PGE,) were 
coincidental, and thus a single curve was used to 
assay both E prostaglandins (Fig. 1). 
Epidermal PG Levels 
Using epidermis from 5 guinea pigs, the amounts 
ofPGE,, PGE, and PGF2a were found to be 24.6 ± 
2.7, 15.2 ± 2.8, and 22.2 ± 3.6 ng/gm wet weight 
(mean ± SD). The corresponding values for 3 
samples of human epidermis (surgical) were 53.5 ± 
7.9, 46.1 ± 7.8, and45.1 ± 9.1 ng/gm, respectively. 
Effect of Isoproterenol on PG Levels 
At a concentration of 10- • M, DL-isoproterenol 
raised the total PGE levels (PGE, + PGE,) in 
guinea-pig epidermal slices (4 animals) to 72.9 ± 
12.6 ng/gm wet weight from the control value of 
36.2 ± 14.6. At 2 x 10-• M, the value was 188.9 ± 
28.4. The effect of PGF,a was less pronounced; the 
control value (22.2 ± 3.6) was unchanged (18.7 ± 
5.1) by the presence of isoproterenol (lo-• M) and 
was raised to 43.3 ± 2.4 ng at the higher concentra-
tion (2 .x 10-• M). All increases above the control 
values were statistically significant. 
Effect of PGs on Epidermal cAMP Levels 
Incubation of guinea-pig epidermal slices (4 
animals) with PGE,. under conditions where 
cAMP phosphodiesterase activity was at least 
partially blocked by theophylline, resulted in 
cAMP levels of 5.00 ± 1.23 pmoles/mg wet weight 
when PGE, was present at 3 x 10·• M concentra-
tion, and 6.84 ± 1.28 pmoles with PGE, at 6 x w-• 
M. In the absence of PGs, cAMP level was 0.74 ± 
0.19 pmoles. PGE, increased this value to 1.24 ± 
0.29 at a concentration of 6 x w-• M. 
DISCUSSION 
In this study PGs were assayed using a commer-
cial immunoassay kit. From data supplied with the 
kits, there was a possibility of cross-reactivity of 
the anti-PGB sera to PGA, present. These data 
indicated that, for instance, 100 pg of PGA, would 
produce about 111 of the amount of inhibition due 
to 100 pg of PGB. However, there is no evidence 
that PGA, is present in epidermis, certainly not in 
amounts comparable to PGE, and PGE 2. Kit data 
also indicated that PGF '" or PGF '" should not 
interefere unless present in amounts over 100 ng 
per sample. 
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Cross-reactivity of anti-PGF 2 a sera with PGF 1a 
should become significant (> 3% inhibition) only 
if PGF,a were present in excess of3 ng per sample. 
PGE, and E 2 should not interefere unless present 
in excessive amounts ( > 20 ng). Determinations of 
PGF2a were carried out at concentrations of about 
1 ng, when cross-reactivity was judged insignifi-
cant. Cross-reactivity was obviously not a problem 
in samples separated by AgN08 -TLC. 
The main source of error was judged to be the 
decreasing sensitivity with increasing PG content 
of samples (see Fig. 1). For this reason, pilot 
experiments were run to determine dilutions neces-
sary to provide samples with optimum PG content 
as already described. 
The homogenization of tissue in buffer followed 
by ethanol extraction results in PG levels which are 
higher than those observed after direct disruption 
in ethanol [18]. For instance, Jonsson and Anggard 
[21] found levels of 25 and 15 ng ofPGE2 per gm of 
human skin when the homogenization was per-
formed in buffer and ethanol, respectively. The 
concentrations of PGs reported here are probably 
above basal levels even though homogenization in 
buffer was carried out at 0°C. 
Results showed that PGE, was present to about 
the same concentration as PGE,_ The relative 
proportion of these two PGs is governed by availa-
bility of their respective precursor unsaturated 
fatty acids, eicosa-8,11,14-trienoic acid (20:3) and 
20:4, which are present in skin in the ratio of about 
1:8 [22]. Thus PGE, should occur to a much 
greater extent than PGE,_ It is possible that much 
of PGE, is of circulatory origin [23]. 
The conversion of arachidonic acid to PGE, and 
F 2a has been studied by Ziboh and Hsia [13], 
Jonsson and Anggard [21], and Greaves and Mac-
Donald-Gibson [24} using whole human or rat skin, 
and Ziboh using human epidermis [17]. The prin-
cipal product was PGE 2 • In this present study we 
have described the conversion in almost purely 
epidermal preparations of guinea-pig and human 
skin (involved and uninvolved psoriatic skin). The 
reaction is usually studied using 1-"C-20:4 or 
5,6,8,9,11,12,14,15-'H-20:4, whose specific activi-
ties are such that l~tCi of the former can be used as 
a substrate ( 1~tCi = 6 ~tgl whereas the latter ( 1~tCi 
= 0.012 ltg) labels the endogenous pool of free 20:4. 
From available data on the occurrence of 20:4 in 
skin [22] and its distribution between dermis and 
epidermis {25 ), the amount of free 20:4 in the 
epidermal homogenates used in our preparations 
was calculated to be below 0.25 ILg. Thus, the 
endogenous pool was very much smaller than the 
added substrate. Gerstein [26] has found that lipid 
levels in psoriatic plaques were about 50% higher 
than those of unaffected skin, on a wet weight 
basis. Probably the levels of free endogenous 20:4 
in our preparations from psoriatic tissue were 
higher by a similar amount, but again the endoge-
nous pool would be much smaller than the added 
20:4. 
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Results presented here indicate that PGE, and 
E, are released by the catecholamine isoproterenol 
and stimulate epidermal adenyl cyclase, and that 
their synthesis from the precursor 20:4 is reduced 
in psoriatic skin. It is possible that certain PGs 
might play some role in the control of intracellular 
levels of cAMP and hence epidermal proliferation 
as current evidence suggests that cAMP may 
control cellular growth [27-32]. Burger et al [27] 
suggested that lowered levels of cAMP at a specific 
point in the cell cycle may trigger cell division. 
Pas tan (33 I has demonstrated a role of cAMP in 
the transcription of DNA after forming a complex 
with cAMP-binding protein which is distinct from 
cAMP-dependent protein kinase. Therefore, a hy-
pothesis can be proposed that psoriatic epidermal 
proliferation might result from the reduced ability 
of psoriatic epidermis to synthesize those PGs 
which stimulate adenyl cyclase to control cellular 
growth. 
Voorhees and Duell (34 I hypothesized that epi-
dermal growth control is mediated through the 
epinephrine-activated cascade of cAMP. It is 
known that epinephrine depresses epidermal cell 
division by 50% [35]. Reexamining the effect of 
epinephrine on epidermal adenyl cyclase, in rela-
tion to inhibitory action on epidermal cell division, 
Bronstad et a! (36 I observed that the lowest 
concentration of epinephrine required to stimulate 
adenyl cyclase was I0- 7 Min hamster epidermis. 
He stated that this concentration was higher than 
the concentration necessary to stimulate adenyl 
cyclase in those tissues which were known to be the 
physiologic target organs for the hormone and 
commented that the physiologic activator of epi· 
dermal cyclase might not be epinephrine but 
another hormone of glandular or local origin. 
Activation of human epidermal adenyl cyclase was 
observed at 1 x 10-• M by Wright et a! [12]. We 
have shown that PGs are released in guinea-pig 
epidermis following isoproterenol stimulation at a 
concentration of 10-• M, and activation of adenyl 
cyclase with PGE, and PGE, occurred at concen-
trations of3 x 10-• M and 6 x 10-• M, respectively. 
Activation of epidermal adenyl cyclase with other 
PGs such as PGA or PGB is under investigation. 
The data will provide information on the physio-
logic activators of epidermal adenyl cyclase. 
Evidence has suggested that certain PGs play a 
role as mediators of inflammation [1]. Their associ-
ation with allergic contact dermatitis [37,38], ul-
traviolet inflammation (39], or burning syndrome 
[40] has been demonstrated. In view of the evi-
dence that they may play a role in wound healing 
[1], stimulating collagen synthesis (41 ], and kera-
tinization [42-44], their appearance may be re-
lated to secondary changes in skin initiated by 
inflammation. 
We are not certain whether the observed reduced 
synthesis of PGE, and PGF 2a is specific for the 
psoriatic lesions or whether it may simply repre-
sent a secondary phenomenon due to the acceler-
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ated epidermal proliferation of psoriasis. Further 
studies will be needed to verify our hypothesis that 
PGs are a basic physiologic modulator of epidermal 
growth through their regulation of levels of cAMP. 
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